• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis.

作者信息

Malinowski S M, Pulido J S, Goeken N E, Brown C K, Folk J C

机构信息

Department of Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City.

出版信息

Ophthalmology. 1993 Aug;100(8):1199-205. doi: 10.1016/s0161-6420(93)31505-8.

DOI:10.1016/s0161-6420(93)31505-8
PMID:8341502
Abstract

PURPOSE

To establish a human leukocyte antigen (HLA) association in a homogeneous population of patients with pars planitis.

METHODS

A strict set of inclusion parameters was established for the diagnosis of pars planitis. Forty patients with pars planitis who met these criteria underwent HLA analysis of class I and II phenotypes.

RESULTS

HLA-B8 was present in 15 (37.5%) of 40 patients versus 85 (19.7%) of 431 controls (relative risk, 2.44; P = 0.011). HLA-B51 was present in 9 (22.5%) of 40 patients versus 51 (11.8%) of 431 controls (relative risk, 2.16; P = 0.049). HLA-DR2 was present in 27 (67.5%) of 40 patients versus 121 (28.0%) of 431 controls (relative risk, 5.32; P < 0.0001). HLA-DR2 has been associated with multiple sclerosis (MS). Exclusion of five patients with pars planitis in whom MS subsequently developed did not change the significance of these findings.

CONCLUSIONS

The strongest association of pars planitis with HLA-DR2 and the temporal development of MS in some patients with pars planitis further supports an association between pars planitis and MS.

摘要

相似文献

1
The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis.
Ophthalmology. 1993 Aug;100(8):1199-205. doi: 10.1016/s0161-6420(93)31505-8.
2
Pars planitis: clinical features and class II HLA associations.
Ophthalmology. 1999 Mar;106(3):594-9. doi: 10.1016/S0161-6420(99)90122-7.
3
[Clinical and epidemiological features and HLA association in patients with pars planitis].
Med Clin (Barc). 2010 Jul 10;135(5):205-8. doi: 10.1016/j.medcli.2010.02.029. Epub 2010 May 26.
4
The association of HLA class II with pars planitis.
Am J Ophthalmol. 2001 May;131(5):657-9. doi: 10.1016/s0002-9394(00)00863-1.
5
Long-term visual outcome and complications associated with pars planitis.中间葡萄膜炎的长期视力预后及相关并发症
Ophthalmology. 1993 Jun;100(6):818-24; discussion 825. doi: 10.1016/s0161-6420(93)31567-8.
6
Genetic polymorphism of HLA DR in a Scottish population of patients with pars planitis.
Eur J Ophthalmol. 2003 Jun;13(5):433-8. doi: 10.1177/112067210301300503.
7
Immunopathogenic Background of Pars Planitis.睫状体平坦部炎的免疫致病背景
Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):127-37. doi: 10.1007/s00005-015-0361-y. Epub 2015 Oct 5.
8
HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes.多发性硬化症中的人类白细胞抗原(HLA)图谱提示了两种疾病形式以及保护性单倍型的存在。
J Neurol Sci. 1982 Mar;53(3):519-29. doi: 10.1016/0022-510x(82)90248-9.
9
Pars planitis: epidemiology, treatment, and association with multiple sclerosis.
Ocul Immunol Inflamm. 2001 Jun;9(2):93-102. doi: 10.1076/ocii.9.2.93.3975.
10
The appearance of pars planitis in multiple sclerosis.
Coll Antropol. 2005 Jun;29(1):203-6.

引用本文的文献

1
Demyelinating plaque-associated uveitis.脱髓鞘斑块相关性葡萄膜炎。
Graefes Arch Clin Exp Ophthalmol. 2024 Feb;262(2):575-582. doi: 10.1007/s00417-023-06270-3. Epub 2023 Oct 19.
2
Clinical characteristics of intermediate uveitis in adults according to criteria of the SUN working group.根据 SUN 工作组的标准,成人中间葡萄膜炎的临床特征。
Int Ophthalmol. 2023 Oct;43(10):3681-3693. doi: 10.1007/s10792-023-02778-z. Epub 2023 Jul 3.
3
Bilateral exudative retinal detachment, unusual pattern of uveitis with multiple sclerosis.
双侧渗出性视网膜脱离,伴有多发性硬化的不寻常葡萄膜炎模式。
J Ophthalmic Inflamm Infect. 2023 Mar 22;13(1):13. doi: 10.1186/s12348-023-00337-2.
4
Myelin Basic Protein Fragmentation by Engineered Human Proteasomes with Different Catalytic Phenotypes Revealed Direct Peptide Ligands of MS-Associated and Protective HLA Class I Molecules.工程化人类蛋白酶体对髓鞘碱性蛋白片段的切割揭示了与 MS 相关的和保护性 HLA Ⅰ类分子的直接肽配体。
Int J Mol Sci. 2023 Jan 20;24(3):2091. doi: 10.3390/ijms24032091.
5
Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis.多发性硬化相关性中间葡萄膜炎的分类标准。
Am J Ophthalmol. 2021 Aug;228:72-79. doi: 10.1016/j.ajo.2021.03.044. Epub 2021 May 11.
6
Classification Criteria For Pars Planitis.帕斯卡氏眼病分类标准。
Am J Ophthalmol. 2021 Aug;228:268-274. doi: 10.1016/j.ajo.2021.03.045. Epub 2021 Apr 15.
7
Classification Criteria for Intermediate Uveitis, Non-Pars Planitis Type.中间葡萄膜炎,非结节性视网膜血管炎型的分类标准。
Am J Ophthalmol. 2021 Aug;228:159-164. doi: 10.1016/j.ajo.2021.03.054. Epub 2021 Apr 9.
8
Adalimumab Induced or Provoked MS in Patient with Autoimmune Uveitis: A Case Report and Review of the Literature.阿达木单抗诱发或激发自身免疫性葡萄膜炎患者发生多发性硬化症:一例报告及文献复习
Case Rep Med. 2016;2016:1423131. doi: 10.1155/2016/1423131. Epub 2016 Oct 20.
9
Immunopathogenic Background of Pars Planitis.睫状体平坦部炎的免疫致病背景
Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):127-37. doi: 10.1007/s00005-015-0361-y. Epub 2015 Oct 5.
10
[Uveitis in multiple sclerosis : Overview and perspectives].[多发性硬化症中的葡萄膜炎:概述与展望]
Ophthalmologe. 2014 Aug;111(8):733-9. doi: 10.1007/s00347-013-2984-x.